Ignite Creation Date:
2024-05-06 @ 3:39 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02340689
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2014-09-16
Brief Title:
Primary Hyperoxaluria Mutation GenotypingPhenotyping
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Genetic Characterization and GenotypePhenotype Correlations in Primary Hyperoxaluria
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff
Detailed Description:
During your study visit we will draw one tube about two teaspoons 1 to 1 ½ teaspoons for children of blood from your arm White blood cells from the sample will be used as a source of DNA for genetic testing We will use the DNA to try to identify mutations changes in one of the genes that can cause primary hyperoxaluria This will be done by comparing it with the structure of these genes in normal individuals patients with primary hyperoxaluria and family members of primary hyperoxaluria patients In family members of primary hyperoxaluria patients a 24 hr urine test may also be collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None